Drug Patent Expirations in November 2008

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in November 2008

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
ALKERAN Glaxosmithkline melphalan hydrochloride 4,997,651 Nov 18, 2008
BREVIBLOC Baxter Hlthcare Corp esmolol hydrochloride 5,017,609 Nov 21, 2008
BUSPAR Bristol Myers Squibb buspirone hydrochloride 5,015,646 Nov 14, 2008
COVERA-HS Gd Searle Llc verapamil hydrochloride 5,030,456 Nov 7, 2008
DYNACIRC CR Smithkline Beecham isradipine 5,030,456 Nov 7, 2008
NEUROLITE Lantheus Medcl technetium tc-99m bicisate kit 5,279,811 Nov 23, 2008
NEURONTIN Parke Davis gabapentin 4,894,476 Nov 2, 2008
NEURONTIN Pfizer Pharms gabapentin 4,894,476 Nov 2, 2008
NUVIGIL Cephalon armodafinil 4,927,855 Nov 22, 2008
PRELAY Sankyo troglitazone 4,572,912 Nov 9, 2008
REZULIN Pfizer Pharms troglitazone 4,572,912 Nov 9, 2008

Courtesy of DrugPatentWatch.com


Leave a Reply